Alexander Kohlmann
AstraZeneca (United States)(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Cancer Genomics and Diagnostics, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Olaparib for Metastatic Castration-Resistant Prostate Cancer(2020)2,172 cited
- → Landscape of genetic lesions in 944 patients with myelodysplastic syndromes(2013)1,503 cited
- → Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group(2010)672 cited
- → Myelodysplastic Cells in Patients Reprogram Mesenchymal Stromal Cells to Establish a Transplantable Stem Cell Niche Disease Unit(2014)372 cited
- → Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non–Small Cell Lung Cancer(2017)330 cited
- → EZH2 mutations are frequent and represent an early event in follicular lymphoma(2013)321 cited
- → SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)(2012)304 cited
- → Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1(2010)290 cited
- → Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles(2002)271 cited